Cell Viability Assays Market - Growth, Trends, and Forecast (2019 - 2024)

The Cell Viability Assays Market is segmented by product, application (drug discovery and development, stem cell research, clinical and diagnostic applications, and other applications), and geography.

Market Snapshot

Cell Viability Assays Market 1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Europe

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Cell Viability Assays Market

The major factors for the growth of the cell viability assays market include the growing burden of chronic and infectious diseases, rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics.

  • Chronic diseases are among the primary global challenges, and according to the WHO (Word Health Organization) estimates, these diseases account for approximately 60% of all deaths, globally. According to the WHO, chronic diseases are expected to increase by 57%, by 2020.
  •  The increased demand for healthcare systems, due to the rise in chronic diseases, has become a major concern.
  • Furthermore, according to the WHO, in 2014, nearly four out of every five deaths in the developing countries resulted from chronic diseases.
  • As per the Centers for Disease Control and Prevention (CDC), in 2017, chronic diseases were the leading cause of death and disability in the United States, and 133 million Americans, i.e., 45% of the population, had at least one chronic disease. In addition, the rise of age- and lifestyle-related chronic diseases is increasing demand for, and spending on, healthcare.
  • In the emerging markets, cancer and heart diseases are becoming the main causes of death, as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. 
  • According to the CDC estimates, these diseases are responsible for majority of deaths in the United States, causing more than 1.7 million deaths, annually. Thus, the growing burden of chronic diseases is expected to boost cell-based research, resulting in the high growth of the market.

Scope of the Report

As per the scope of this report, cell viability assay is used to determine the ability of organs, cells, or tissues to maintain or recover viability. This can assay the mechanical activity, motility, contraction, etc. Counting cells using viability dyes can provide both the rate of proliferation and the percentage of viable cells.

Product
Consumables
Reagents
Assay Kits
Tetrazolium Reduction Assay Kits
Resazurin Cell Viability Assay Kits
Calcein AM Cell Viability Assay Kits
Other Assay Kits
Other Consumables
Instruments
Automated Cell Counters
Flow Cytometers
Spectrophotometers
Other Instruments
Application
Drug Discovery and Development
Stem Cell Research
Clinical and Diagnostic Applications
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Stem Cell Research Application is Estimated to Register the Fastest Growth Over the Forecast Period

By application, the stem cell research segment is estimated to register the fastest growth, owing to the rising R&D activities and funding from various organizations. According to the data available on the portal for National Institutes of Health (NIH), an estimated USD 1,748 million was granted for stem cell research in FY 2018. In the United States, different cell-based treatment grew significantly over the recent years. In 2015, there were more than 570 cell-based treatment centers across the United States. Thus, the increase in the number of such centers helped drive stem cell research. Furthermore, the support is increasing, with the rise in the number of medical communities and government initiatives actively promoting the use of stem cells for the treatment of more than 100 diseases. Thus, considering all the aforementioned factors, the market is expected to witness high growth over the forecast period.

Cell Viability Assays Market 2

To understand key trends, Download Sample Report

North America is Expected to Dominate the Market Over the Forecast Period

North America holds a major share for the cell viability assays market, and it is expected to witness a similar trend over the forecast period, without significant fluctuations. The region is dominating the market, due to various factors, like the increasing incidences of chronic diseases, rise in investment initiatives by governments, and high-quality infrastructure for clinical and laboratory research. Various additional advantages, such as the availability of insurance coverage for laboratory testing procedures, rising healthcare and R&D expenditures, and the presence of well-structured distribution channels in the region, are also supporting the growth of the market. Furthermore, in the United States, there is a rise in the funding for the cell-based research, which is expected to propel the overall growth of the cell viability assay market, over the forecast period.

Cell Viability Assays Market 3

To understand geography trends, Download Sample Report

Competitive Landscape

The market studied is fragmented, owing to the presence of various small and large market players. Some of the market players are Abcam PLC, Becton Dickinson & Company, Bio-Rad Laboratories, Biotek Instruments, Creative Bioarray, GE Healthcare, Merck KGaA, Perkin Elmer, Promega Corporation, and Thermo Fischer Scientific Inc.

Major Players

  1. Abcam PLC
  2. Becton Dickinson & Company
  3. Bio-Rad Laboratories
  4. Merck KGaA
  5. Thermo Fischer Scientific Inc.

* Complete list of players covered available in the table of contents below

Cell Viability Assays Market 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Chronic and Infectious Diseases

      2. 4.2.2 Rising Demand for Cell-based Assays in Research

      3. 4.2.3 Increasing Focus on the Development of Cell-based Therapeutics

    3. 4.3 Market Restraints

      1. 4.3.1 Limitations of the Assays

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Consumables

        1. 5.1.1.1 Reagents

        2. 5.1.1.2 Assay Kits

          1. 5.1.1.2.1 Tetrazolium Reduction Assay Kits

          2. 5.1.1.2.2 Resazurin Cell Viability Assay Kits

          3. 5.1.1.2.3 Calcein AM Cell Viability Assay Kits

          4. 5.1.1.2.4 Other Assay Kits

        3. 5.1.1.3 Other Consumables

      2. 5.1.2 Instruments

        1. 5.1.2.1 Automated Cell Counters

        2. 5.1.2.2 Flow Cytometers

        3. 5.1.2.3 Spectrophotometers

        4. 5.1.2.4 Other Instruments

    2. 5.2 Application

      1. 5.2.1 Drug Discovery and Development

      2. 5.2.2 Stem Cell Research

      3. 5.2.3 Clinical and Diagnostic Applications

      4. 5.2.4 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abcam PLC

      2. 6.1.2 Becton Dickinson & Company

      3. 6.1.3 Bio-Rad Laboratories

      4. 6.1.4 Biotek Instruments

      5. 6.1.5 Creative Bioarray

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Perkin Elmer

      9. 6.1.9 Promega Corporation

      10. 6.1.10 Thermo Fischer Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information